All Pharma News
Lyndra Announces Positive Data from Phase 3 Study with Oral Weekly Risperidone

Lyndra Announces Positive Data from Phase 3 Study with Oral Weekly Risperidone
BUSINESSWIRE
04 Jan 2024
Share Share
Sun Pharma to acquire 16.7% stake in Lyndra Therapeutics for $30 mn

Sun Pharma to acquire 16.7% stake in Lyndra Therapeutics for $30 mn
INDIAN PHARMA POST
02 Jan 2024
Share Share
Lyndra Therapeutics raises US$101 million in Series E funding

Lyndra Therapeutics raises US$101 million in Series E funding
INDIAN PHARMA POST
25 Dec 2023
Share Share
Lyndra Therapeutics Raises $101 Million in Series E Funding

Lyndra Therapeutics Raises $101 Million in Series E Funding
BUSINESSWIRE
21 Dec 2023
Share Share
Lyndra lays off 23% of workers

Lyndra lays off 23% of workers
Kyle LaHucik ENDPTS
15 Sep 2023
Share Share
Lyndra Announces Leadership Changes, Update on Pivotal Trial Progress

Lyndra Announces Leadership Changes, Update on Pivotal Trial Progress
BUSINESSWIRE
17 Jul 2023
Share Share
Lyndra eyes $180M Series D for potential 2026 launch of schizophrenia med

Lyndra eyes $180M Series D for potential 2026 launch of schizophrenia med
ENDPTS
09 Jun 2023
Share Share
Lyndra Therapeutics Presents Data on Long-Acting Oral Weekly Risperidone

Lyndra Therapeutics Presents Data on Long-Acting Oral Weekly Risperidone
BUSINESSWIRE
31 May 2023
Share Share
Lyndra Doses 1st Trial Participant in Pivotal Study of Oral Weekly Risperidone

Lyndra Doses 1st Trial Participant in Pivotal Study of Oral Weekly Risperidone
BUSINESSWIRE
09 May 2023
Share Share
Lyndra Therapeutics Announces New Board Members and Chief Technology Officer

Lyndra Therapeutics Announces New Board Members and Chief Technology Officer
BUSINESSWIRE
05 Jan 2023
Share Share